Company: EDSA
Filing Date: 2025-03-11
Form Type: 424B3
Source: 0001171843-25-001403
Chunk: 24

Company: Edesa Biotech, Inc.
Filing Date: 2025-03-11
Form: 424B3
Chunk 24
---
, Quarterly Reports on Form 10-Q, Current Reports on Form
8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable
after we electronically file such material with or otherwise furnish it to the SEC.

We have filed with the SEC a registration
statement under the Securities Act, relating to the offering of these securities. The registration statement, including the attached exhibits,
contains additional relevant information about us and the securities. This prospectus does not contain all of the information set forth
in the registration statement. You can obtain a copy of the registration statement for free at www.sec.gov. The registration statement
and the documents referred to below under “Incorporation of Certain Information by Reference” are also available on our website,
www.edesabiotech.com.

We have not incorporated by reference into this prospectus the
information on our website, and you should not consider it to be a part of this prospectus.

| 20 |

### INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
The SEC allows us to “incorporate
by reference” the information we have filed with it, which means that we can disclose important information to you by referring
you to those documents. The information we incorporate by reference is an important part of this prospectus, and later information that
we file with the SEC will automatically update and supersede this information. We incorporate by reference the documents listed below
and any future documents (excluding information furnished pursuant to Items 2.02 and 7.01 of Form 8-K) we file with the SEC pursuant to
Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, subsequent to the date of this prospectus and prior to the termination of the
offering:

All reports and other documents that
we file with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this prospectus but before the termination
of the offering of the securities hereunder will also be considered to be incorporated by reference into this prospectus from the date
of the filing of these reports and documents, and will supersede the information herein; provided, however, that all reports, exhibits
and other information that we “furnish” to the SEC will not be considered incorporated by reference into this prospectus.
We undertake to provide without charge to each person (